The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer
Cell Proliferation · 2024-08 · 57 (8)
DOI: 10.1111/cpr.13641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 08.04.2024. Verfasst von Luca Grisetti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Italiana Fegato - ONLUS, Liver Cancer Unit, Trieste, Italy. Hauptthemen laut MEDLINE: Aurora Kinase A, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Grant C3B, Università degli Studi di Trieste, Dipartimento di Scenze della Vita, Department of Science and Technology (DOST)-PCHRD.
Abstract (Originalsprache)
Aurora Kinase A (AURKA) plays a central role as a serine/threonine kinase in regulating cell cycle progression and mitotic functions. Over the years, extensive research has revealed the multifaceted roles of AURKA in cancer development and progression. AURKA's dysregulation is frequently observed in various human cancers, including hepatocellular carcinoma (HCC). Its overexpression in HCC has been associated with aggressive phenotypes and poor clinical outcomes. This review comprehensively explores the molecular mechanisms underlying AURKA expression in HCC and its functional implications in cell migration, invasion, epithelial‐to‐mesenchymal transition, metastasis, stemness, and drug resistance. This work focuses on the clinical significance of AURKA as a diagnostic and prognostic biomarker for HCC. High levels of AURKA expression have been correlated with shorter overall and disease‐free survival in various cohorts, highlighting its potential utility as a sensitive prognostic indicator. Recent insights into AURKA's role in modulating the tumour microenvironment, particularly immune cell recruitment, may provide valuable information for personalized treatment strategies. AURKA's critical involvement in modulating cellular pathways and its overexpression in cancer makes it an attractive target for anticancer therapies. This review discusses the evidence about novel and selective AURKA inhibitors for more effective treatments for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fondazione Italiana Fegato - ONLUS, Liver Cancer Unit, Trieste, Italy.
- Department of Life Sciences, Università degli Studi di Trieste, Trieste, Italy.
ORCID-Profile: Devis Pascut
Förderung
- EU Grant C3B
- Università degli Studi di Trieste, Dipartimento di Scenze della Vita
- Department of Science and Technology (DOST)-PCHRD
- Programma di cooperazione Interreg V-A Italia -Slovenia 2014-2020
- Italian Liver Foundation
- Università degli Studi di Trieste
- Department of Science and Technology, Republic of the Philippines
- Fondazione Italiana Fegato Onlus
Zitieren
APA
Grisetti, L., Garcia, C. J. C., Saponaro, A. A., Tiribelli, C., & Pascut, D. (2024). The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Proliferation, 57(8). https://doi.org/10.1111/cpr.13641
Vancouver
Grisetti L, Garcia CJC, Saponaro AA, Tiribelli C, Pascut D. The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer. Cell Proliferation. 2024;57(8). doi:10.1111/cpr.13641
BibTeX
@article{Grisetti2024,
author = {Grisetti, Luca and Garcia, Clarissa J C and Saponaro, Anna A and Tiribelli, Claudio and Pascut, Devis},
title = {The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {8},
doi = {10.1111/cpr.13641}
}
EUVIMED